RADCOM (RDCM) 20-F 26 Mar 15 2014 FY Annual report (foreign) Financial data

Document_and_Entity_Informatio

Document and Entity Information	12 Months Ended
	Dec. 31, 2014
Document and Entity Information [Abstract]
Document Type	20-F
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Entity Registrant Name	RADCOM LTD
Entity Central Index Key	1016838
Current Fiscal Year End Date	-19
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding	8,447,307
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
CURRENT ASSETS:
Cash and cash equivalents	$6,848	$1,185
Restricted bank deposits	32	1,505
Trade receivables (net of allowances for doubtful accounts amounted to $20 as of December 31, 2013)	5,477	5,723
Inventories	2,699	4,352
Other accounts receivable and prepaid expenses	1,411	3,092
Total current assets	16,467	15,857
SEVERANCE PAY FUND	3,051	3,535
OTHER LONG -TERM RECEIVABLES	600
PROPERTY AND EQUIPMENT, NET	200	253
Total assets	20,318	19,645
CURRENT LIABILITIES:
Short-term bank credit, net		629
Trade Payables	1,524	2,257
Employees and payroll accruals	2,377	2,109
Deferred revenues and advances from customers	765	1,305
Other accounts payable and accrued expenses	1,739	1,795
Total current liabilities	6,405	8,095
LONG-TERM LIABILITIES:
Deferred revenues	198	107
Accrued severance pay	3,453	3,944
Total long-term liabilities	3,651	4,051
Total liabilities	10,056	12,146
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' EQUITY:
Share capital: Ordinary Shares of NIS 0.20 par value: 9,997,670 shares authorized at December 31, 2014 and 2013; 8,447,307 and 7,940,340 shares issued and outstanding at December 31, 2014 and 2013, respectively	361	335
Additional paid-in capital	68,059	65,791
Accumulated other comprehensive loss	-1,062	-805
Accumulated deficit	-57,096	-57,822
Total shareholders' equity	10,262	7,499
Total liabilities and shareholders' equity	$20,318	$19,645

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
CONSOLIDATED BALANCE SHEETS [Abstract]
Trade receivables, allowances for doubtful accounts	$0	$20
Ordinary Shares, par value per share	$0.20	$0.20
Ordinary Shares, shares authorized	9,997,670	9,997,670
Ordinary Shares, shares issued	8,447,307	7,940,340
Ordinary Shares, shares outstanding	8,447,307	7,940,340

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenues:
Products	$20,547	$17,917	$12,480
Services	3,089	2,565	3,306
Total revenues	23,636	20,482	15,786
Cost of revenues :
Products	8,350	7,540	5,765
Services	343	350	417
Total cost of revenues	8,693	7,890	6,182
Gross profit	14,943	12,592	9,604
Operating expenses:
Research and development	5,812	5,615	6,102
Less - royalty-bearing participation	1,664	1,537	1,567
Research and development, net	4,148	4,078	4,535
Selling and marketing, net	7,295	7,592	8,515
General and administrative	2,262	2,051	2,107
Total operating expenses	13,705	13,721	15,157
Operating income (loss)	1,238	-1,129	-5,553
Financial expenses, net	-332	-291	-314
Loss before taxes on income	906	-1,420	-5,867
Taxes on income	-180		-120
Net income (loss)	$726	($1,420)	($5,987)
Net profit (loss) per share:
Basic net income (loss) per Ordinary Share	$0.09	($0.19)	($0.93)
Diluted net income (loss) per Ordinary Share	$0.08	($0.19)	($0.93)
Weighted average number of Ordinary Share used in computing basic net income (loss) per share	8,088,974	7,340,056	6,442,068
Weighted average number of Ordinary Share used in computing diluted net income (loss) per share	8,592,387	7,340,056	6,442,068

CONSOLIDATED_STATMENTS_OF_COMP

CONSOLIDATED STATMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) [Abstract]
Net income (loss)	$726	($1,420)	($5,987)
Other comprehensive loss:
Foreign currency translation adjustments	-257	-483	-125
Other comprehensive loss	-257	-483	-125
Comprehensive income (loss)	$469	($1,903)	($6,112)

CONSOLIDATED_STATEMENTS_OF_SHA

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (USD $)	Total	Share capital [Member]		Additional paid-in capital [Member]	Accumulated other comprehensive loss [Member]	Accumulated deficit [Member]
In Thousands, except Share data
Balance at Dec. 31, 2011	$10,392	$250		$60,754	($197)	($50,415)
Balance, shares at Dec. 31, 2011		6,415,698
Share-based compensation	672			672
Exercise of options	45	1		44
Exercise of options, shares		34,082
Net income (loss)	-5,987					-5,987
Other comprehensive loss	-125				-125
Balance at Dec. 31, 2012	4,997	251		61,470	-322	-56,402
Balance, shares at Dec. 31, 2012		6,449,780
Issuance of shares and warrants, net of issuance expenses of $ 35 (private placement)	3,424	68		3,356
Issuance of shares and warrants, net of issuance expenses of $ 35 (private placement), shares		1,239,639
Share-based compensation	499			499
Exercise of warrants	256	4		252
Exercise of warrants, shares		73,333
Exercise of options	226	12		214
Exercise of options, shares		184,588
Net income (loss)	-1,420					-1,420
Other comprehensive loss	-483				-483
Balance at Dec. 31, 2013	7,499	335		65,791	-805	-57,822
Balance, shares at Dec. 31, 2013	7,940,340	7,947,340
Share-based compensation	579			579
Exercise of warrants	21		[1]	21
Exercise of warrants, shares		5,974
Exercise of options	1,694	26		1,668
Exercise of options, shares	79,307	493,993
Net income (loss)	726					726
Other comprehensive loss	-257				-257
Balance at Dec. 31, 2014	$10,262	$361		$68,059	($1,062)	($57,096)
Balance, shares at Dec. 31, 2014	8,447,307	8,447,307
[1]	Represent an amount lower than $1.

CONSOLIDATED_STATEMENTS_OF_SHA1

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY [Abstract]
Private placement issuance expenses	$35

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows used in operating activities:
Net income (loss)	$726	($1,420)	($5,987)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation	87	108	119
Share-based compensation	579	499	672
Increase (decrease) in severance pay, net	-7	-19	10
Decrease (increase) in trade receivables net of allowance for doubtful accounts	61	-2,716	2,080
Decrease in other current assets	804	348	767
Decrease (increase) in inventories	1,379	2,131	-222
Increase (decrease) in trade payables	-705	348	-775
Increase (decrease) in employees and payroll accrued	276	123	-88
Increase (decrease) in other accounts payable and accrued expenses	584	-9	-131
Interest and linkage on short-term loan and restricted cash	-4	8	12
Increase (decrease) in deferred revenue and advances from customers	-394	-1,531	1,082
Net cash provided (used) in operating activities	3,386	-2,130	-2,461
Cash flows used in investing activities:
Investment in Restricted bank deposits		-38	-1,437
Maturity of Restricted bank deposits	1,477
Purchase of property and equipment	-65	-88	-66
Net cash provided (used) in investing activities	1,412	-126	-1,503
Cash flows from financing activities:
Receipts (repayment) of short-term bank credit, net	-629	-429	1,058
Receipts (repayment) of short-term loan (includes $750 from related party)		-1,550	1,500
Proceeds from issuance of shares and warrants , net of issuance expenses of $ 35 (private placement)		3,424
Exercise of warrants	21	256
Exercise of options	1,694	226	45
Net cash provided by financing activities	1,086	1,927	2,603
Foreign currency translation adjustments on cash and cash equivalents	-221	40	-66
Increase in cash and cash equivalents	5,663	-289	-1,427
Cash and cash equivalents at beginning of year	1,185	1,474	2,901
Cash and cash equivalents at end of year	6,848	1,185	1,474
Non-cash investing activities:
Purchase of property and equipment on credit	4	30	19
Inventory transferred to be used as property and equipment			4
Cash paid during the year for:
Interest	13	43	6
Taxes on income	$180		$120

CONSOLIDATED_STATEMENTS_OF_CAS1

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)	1 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Nov. 30, 2012	Nov. 30, 2012	Dec. 31, 2013	Dec. 31, 2012
	USD ($)	ILS	USD ($)	USD ($)
CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]
Loan proceeds from related party	$750	2,900		$750
Private placement issuance expenses			$35

GENERAL

GENERAL	12 Months Ended
	Dec. 31, 2014
GENERAL [Abstract]
GENERAL	NOTE 1:-     GENERAL
	a.        RADCOM Ltd (the "Company") is an Israeli corporation which provides innovative service assurance and customer experience management solutions for leading telecom operators and communications service providers. The Company specializes in solutions for next-generation mobile and fixed networks, including LTE, VoLTE, IMS, VoIP, UMTS/GSM and mobile broadband. RADCOM's comprehensive, carrier-grade solutions are designed for big data analytics on terabit networks, and are used to prevent service provider revenue leakage and to enhance customer care management. The Company's products interact with policy management to provide self-optimizing network solutions. RADCOM's shares are listed on the NASDAQ Capital Market under the symbol RDCM.
	In February 2014, the MaveriQ was officially launched, and replaced the Company's OmniQ solution.  The MaveriQ is a unique, comprehensive, next-generation probe-based service assurance and CEM solution, designed to enable telecommunications carriers to carry out end-to-end voice and data quality monitoring and to manage their networks and services. The MaveriQ offers users a full array of drilldown and troubleshooting tools, delivering a comprehensive, integrated network service view that facilitates performance monitoring, fault detection and network and service troubleshooting.
	The Company has wholly-owned subsidiaries in the United States, Brazil and India, that are primarily engaged in the sales, marketing and customer support of the Company's products in North America, Brazil and India, respectively.
	b.      In December 2014, one of the Company's customers in Latin America sent a termination announcement to the agreement between the parties, claiming for refund of all amounts previously paid and damages. The Company currently concludes that no potential loss with respect to claim to refund or damages fee is considered probable.
	In addition, in light of this termination letter the Company took an inventory and related costs write-off charge of approximately $1,815 thousand during the year ended December 31, 2014. Such costs are related to equipment that was shipped to this customer for which revenue criteria have not been met. The write-off was charged to costs of revenue and selling and marketing, net expenses in a total amount of $1,639 and $176, respectively.
	c.       The Company has an accumulated deficit of $57,096 as of December 31, 2014. The Company has managed its liquidity during this time through a series of cost reduction initiatives, including reduction in workforce and private placement transactions. In addition, in 2014 the Company became profitable and generated $3,386 from its operating activities. The Company believes that its existing capital resources and expected cash flows from operations will be adequate to satisfy its expected liquidity requirements at least through the end of March 2016. The Company's foregoing estimate is based, among others, on its current backlog and pipeline.

SIGNIFICANT_ACCOUNTING_POLICIE

SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2014
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2:-    SIGNIFICANT ACCOUNTING POLICIES
	The consolidated financial statements are prepared according to United States generally accepted accounting principles ("U.S GAAP").
	a.       Use of estimates:
	The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
	b.       Financial statements in U.S. dollars ("dollar" or "dollars"):
	Most of the Company's and its subsidiaries, other than in Brazil, revenues and costs are denominated in U.S. dollars. Therefore, the Company's management believes the currency of the primary economic environment in which the operations of the Company are conducted is the United States dollar, which is used as the functional currency of the Company.
	Transactions and balances originally denominated in dollars are presented at their original amounts. Transactions and balances in other currencies are re-measured into dollars in accordance with the principles set forth in Statement of Accounting Standards Codification ("ASC") 830 "Foreign Currency Matters".
	Other than in the Company's subsidiary in Brazil, all exchange gains and losses from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the consolidated statement of operations when they arise.
	Amounts in the financial statements representing the dollar equivalent of balances denominated in other currencies do not necessarily represent their real or economic value and such amounts may not necessarily be exchangeable for dollars.
	For the Company's subsidiary in Brazil whose functional currency has been determined to be their local currency, assets and liabilities are translated at year-end exchange rates and statements of income items are translated at average exchange rates prevailing during the year. Such translation adjustments are recorded as a separate component of accumulated other comprehensive loss in shareholders' equity.
	c.       Principles of consolidation:
	The consolidated financial statements include the financial statements of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
	d.       Cash equivalents:
	The Company considers all highly liquid deposit instruments with an original maturity of three months or less at the date of purchase to be cash equivalents.
	e.       Restricted cash:
	Restricted cash is invested in a bank deposit, which is pledged in favor of the bank that provides guarantees to the Company.
	f.       Concentration of credit risk:
	Financial instruments that may subject the Company to significant concentration of credit risk consist mainly of cash and cash equivalents severance pay fund and trade receivables.
	Cash and cash equivalents and are maintained with major financial institutions mainly in Israel. Assets held for severance benefits are maintained with major insurance companies and financial institutions in Israel. Such deposits are not insured. However, management believes that such financial institutions are financially sound and, accordingly, low credit risk exists with respect to these investments.
	The Company grants credit to customers without generally requiring collateral or security. The risk of collection associated with trade receivables is reduced by geographical dispersion of the Company's customer base. The Company establishes an allowance for doubtful accounts based on historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer's ability to pay. Allowance for doubtful accounts amounted to $0 and $20 thousand as of December 31, 2014 and 2013. The Company charges off receivables when they are deemed uncollectible. Actual collection experience may not meet expectations and may result in increased bad debt expense. No bad debt expenses have been recorded during the years ended December 31, 2014, 2013 and 2012. Total write-offs during the years ended December 31, 2014, 2013 and 2012 amounted to $0, $0 and $206, respectively.
	g.       Inventories:
	Inventories are stated at the lower of cost or market value. Cost is determined on a "moving average" basis. Inventory write-downs are provided to cover technological obsolescence, excess inventories and discontinued products.
	Inventory write-down is measured as the difference between the cost of the inventory and market based upon assumptions about future demand, and is charged to the cost of sales. At the point of the loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
	Total inventory write-offs during the years ended December 31, 2014, 2013 and 2012 amounted to $187, $110 and $311, respectively. Following to Note 1b, during the year ended December 31, 2014, the Company recorded additional inventory write-off amounted to $1,005.
	h.       Property and equipment:
	Property and equipment are stated at cost less accumulated depreciation. Maintenance and repairs are charged to operations as incurred.
	Depreciation is calculated on the straight-line method over the estimated useful lives of the assets.
	Annual rates of depreciation are as follows:
			%
	Research and development equipment		25 - 33
	Manufacturing equipment		15 - 33
	Office furniture and equipment		Jul-33
	Leasehold improvements		At the shorter of the lease period or useful life of the leasehold improvement
	i.       Impairment of long-lived assets:
	The Company's long-lived assets are reviewed for impairment in accordance with ASC 360 "property, plants and equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of an asset to be held and used is assessed by a comparison of the carrying amount of the asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. During the years ended December 31, 2014, 2013 and 2012, no impairment losses were identified.
	j.       Revenue recognition:
	Revenues from sales of products are recognized in accordance with ASC No. 605, "Revenue Recognition" when persuasive evidence of an agreement exists, delivery of the product has occurred, the fee is fixed or determinable and collectability is probable.
	Products are typically considered delivered upon shipment. In instances where final acceptance of the product is specified by the customer, and the acceptance is deemed substantive, revenue is deferred until all acceptance criteria have been met. The Company's arrangements generally do not include any provisions for cancellation, termination, or refunds that would significantly impact recognized revenue.
	The Company's revenues are generated from sales to independent distributors and direct customers. The Company has a contract that is standard in substance with its distributors. Based on this contract, sales to distributors are final and distributors have no rights of return or price protection. The Company is not a party to the agreements between distributors and their customers, however the Company recognizes its revenue on a "sale through" basis and therefore revenues from these distributors are deferred until all revenue recognition criteria of the sale to the end customer are met.
	The Company also generates sales through independent representatives. These representatives do not hold any of the Company's inventories, and they do not buy products from the Company. The Company invoices the end-user customers directly, collects payment directly and then pays commissions to the representative for the sales in its territory.
	Revenues in arrangements with multiple deliverables are allocated using the relative selling price method. The selling price for each deliverable is based on vendor-specific objective evidence ("VSOE") if available, third-party evidence ("TPE") if VSOE is not available, or estimated selling price ("ESP") if neither VSOE or TPE is available. The Company determines the BESP based on management estimated selling price by considering several external and internal factors including, but not limited to, pricing practices including discounting, margin objectives, and competition.
	Revenues from fixed price contracts that require significant customization, integration and installation are recognized based on ASC 605-35, "Construction-Type and Production-Type Contracts", using the percentage-of-completion method of accounting based on the ratio of costs related to contract performance incurred to date to the total estimated amount of such costs. The amount of revenue recognized is based on the total fees under the arrangement and the percentage of completion achieved. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are first determined, in the amount of the estimated loss on the entire contact. During the year ended December 31, 2014, the Company recognized revenue amounted to $2,205 from one contract which reflects completion percentage of 78%.
	Under the Company's selling arrangements, the Company provides a one-year warranty, which includes bug fixing and a hardware warranty ("Warranty") for all of its products. Accordingly, the Company records an appropriate provision for Warranty in accordance with ASC 450 "Contingencies" (see also Note 2m). After the Warranty period initially provided with the Company's products, the Company may sell extended warranty contracts on a standalone basis, which includes bug fixing and a hardware warranty. Revenue related to extended warranty contracts is recognized pursuant to ASC 605-20-25, "Separately Priced Extended Warranty and Product Maintenance Contracts." Pursuant to this provision, revenue related to separately priced product maintenance contracts is deferred and recognized over the term of the maintenance period.
	Deferred revenues represent unrecognized fees collected for extended warranty services.
	k.       Cost of revenues:
	Cost of products is comprised of cost of hardware production, employees' salaries and related costs, allocated overhead expenses, warranty expenses, shipping and handling costs, sub-contractors costs, recurring and nonrecurring inventory and indirect taxes write-off, packaging, import taxes, license fees paid to third parties and royalties paid to the Office of the Chief Scientist (the "OCS").
	Cost of services is comprised of cost of hardware maintenance and customer support employees' salaries and related costs.
	l.       Share-based compensation:
	The Company accounts for share-based compensation in accordance with ASC 718 which requires companies to estimate the fair value of share-based payment awards on the grant date using an option-pricing model.
	The Company recognizes compensation expenses for the value of its awards granted based on the accelerated attribution method over the requisite service period of each of the awards, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Estimated forfeitures are based on actual historical pre-vesting forfeitures.
	The Company selected the Black-Scholes option pricing model as the most appropriate fair value method for its stock-options awards. The option-pricing model requires a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected volatility was calculated based upon actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected option term. Expected term is calculated based on the simplified method as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term to the expected life of the options. Historically the Company has not paid dividends and in addition has no foreseeable plans to pay dividends, and therefore use an expected dividend yield of zero in the option pricing model.
	The fair value for options granted in 2014, 2013 and 2012 is estimated at the date of grant with the following weighted average assumptions:
				2014		2013		2012
	Dividend yield				0%		0%		0%
	Expected volatility				70%-74%		74%		80-100%
	Risk-free interest				0.6%-0.8%		0.3%-0.6%		0.3-0.4%
	Expected life (in years)				2.81		2.81		1.5-5.5
	m.      Provision for product warranty:
	The Company's policy is to grant a product warranty for a period of up to 12 months on its products. An extended warranty may be purchased for a longer period. The provision for warranties for all periods through December 31, 2014, is determined based upon the Company's past experience. As of December 31, 2014, the provision for product warranty is immaterial.
	n.       Research and development costs:
	Research and development costs are charged to statement of operations as incurred. ASC 985-20 "Software - Costs of Computer Software to be Sold, Leased or Otherwise Marketed", requires capitalization of certain software development costs subsequent to the establishment of technological feasibility.
	Based on the Company's product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company between completion of the working models and the point at which the products are ready for general release has been insignificant. Therefore, all research and development costs have been expensed.
	o.       Government grants:
	The Company receives royalty-bearing participation, which represents participation of the Government of Israel (specifically from the OCS) in approved programs for research and development. These amounts are recognized on the accrual basis as a reduction in research and development costs as such costs are incurred. Royalties to the OCS are recorded under cost of sales, when the related sales are recognized. See also Note 7a.
The Company received participation from the Israeli Ministry of Economy, commerce and labor, which is a participation of up to 50% of relevant marketing expenses. These grants are presented as a reduction in marketing expenses amounted to $55, $150 and $109 for the years ended December 31, 2014, 2013 and 2012, respectively. See also Note 7a.
p.       Income (loss) per share:
Basic and diluted income (loss) per Ordinary Share of the Company ("Ordinary Shares") are presented in conformity with ASC 260 "Earnings Per Share", for all years presented. Basic income (loss) per Ordinary Share is computed by dividing net income (loss) for each reporting period by the weighted average number of Ordinary Shares outstanding during the period. Diluted income (loss) per Ordinary Share is computed by dividing net income (loss) for each reporting period by the weighted average number of Ordinary Shares outstanding during the period plus any additional Ordinary Shares that would have been outstanding if potentially dilutive securities had been exercised during the period, calculated under the treasury stock method.
Certain securities were not included in the computation of diluted income (loss) per share since they were anti-dilutive. The total weighted average number of shares related to the outstanding options and warrants excluded from the calculation of diluted net income (loss) per share was 1,368,220, 1,353,372 and 1,248,631 as of December 31, 2014, 2013 and 2012, respectively.
q.       Income taxes:
The Company accounts for income taxes in accordance with ASC 740 "Income Taxes". Deferred tax asset and liability account balances are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss and tax credit carryforward. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statement of operations in the period that includes the enactment date. The Company provides a full valuation allowance to reduce deferred tax assets to the extent it believes is more likely than not that such benefits will not be realized.
r.       Income tax uncertainties:
In accordance with ASC 740 "Income Taxes", the Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. When applicable, the Company accounts for interest and penalties related to unrecognized tax benefits as a component of income tax expense.  As of December 31, 2014 and 2013, no liability for unrecognized tax benefits was recorded as a result of the implementation of ASC 740.
s.       Severance pay:
The Company's liability for severance pay for its Israeli employees is calculated pursuant to Israeli severance pay law based on the most recent salary of the employees multiplied by the number of years of employment as of the balance sheet date. After completing one full year of employment, the Company's Israeli employees are entitled to one month's salary for each year of employment or a portion thereof. The Company's liability is partially provided by monthly deposits with severance pay funds, insurance policies and by an accrual. The liability for employee severance pay benefits included on the balance sheet represents the total liability for such severance benefits, while the assets held for severance benefits included on the balance sheet represent the current redemption value of the Company's contributions made to severance pay funds and to insurance policies.
The carrying value of deposited funds includes profits (losses) accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israeli severance pay law or labor agreements.
Effective January 1, 2012, the Company's agreements with new employees in Israel are in accordance with section 14 of the Severance Pay Law - 1963 which provide that the Company's contributions to severance pay fund shall cover its entire severance obligation. Upon termination, the release of the contributed amounts from the fund to the employee shall relieve the Company from any further severance obligation and no additional payments shall be made by the Company to the employee. As a result, the related obligation and amounts deposited on behalf of such obligation are not stated on the balance sheet, as the Company is legally released from severance obligation to employees once the amounts have been deposited, and the Company has no further legal ownership on the amounts deposited.
Severance expenses for the years ended December 31, 2014, 2013 and 2012 amounted to $527, $537 and $588, respectively.
t.       Fair value of financial instruments:
The financial instruments of the Company consist mainly of cash and cash equivalents, restricted bank deposits, trade receivables, trade and other accounts payable and accrued expenses. Due to the short-term nature of such financial instruments, their fair value approximates their carrying value.
u.       Concentrations of business risk:
Although the Company generally uses standard parts and components for products, certain key components used in the products are currently available from only one source, and others are available from a limited number of sources. The Company believes that it will not experience delays in the supply of critical components in the future. If the Company experiences such delays and there is an insufficient inventory of critical components at that time, the Company's operations and financial results would be adversely affected.
The Company relies on a limited number of independent manufacturers, some of which are small, privately held companies, to provide certain assembly services to its specifications. The Company does not have any long-term supply agreements with any third-party manufacturer. If the Company's assembly services are reduced or interrupted, the Company's business, financial condition and results of operations could be adversely affected until the Company is able to establish sufficient assembly services supply from alternative sources. Alternative manufacturing sources may not be able to meet the Company's future requirements, and existing or alternative sources may not continue to be available at favorable prices.
The Company's revenues in any period generally have been, and may continue to be, derived from relatively small numbers of sales with relatively high average revenues per order. Therefore, the loss of any orders or delays in closing such transactions could have an adverse effect on the Company's operations and financial results.
v.       Legal contingencies:
The Company is currently involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss.
w.      Comprehensive loss:
The Company accounts for comprehensive loss in accordance with ASC No. 220, "Comprehensive Income" which establishes standards for the reporting and displays of comprehensive loss and its components in a full set of general purpose financial statements.  Comprehensive loss generally represents all changes in stockholders' equity during the period except those resulting from investments by, or distributions to shareholders. The Company determined that its only item of other comprehensive loss relates to foreign currency translation adjustment and gains or losses on intra-entity foreign currency transactions that are of a long-term investment nature in connection to its subsidiary in Brazil.
x.       Recently issued accounting standards:
1	In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (ASU 2014-09) "Revenue from Contracts with Customers" which supersedes the revenue recognition requirements in "Revenue Recognition"(Topic 605), and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods and services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. The Company is currently in the process of evaluating the impact of the adoption of ASU 2014-09 on its consolidated financial statements.
2	In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity s Ability to Continue as a Going Concern, which defines management's responsibility to assess an entity's ability to continue as a going concern, and to provide related footnote disclosures if there is substantial doubt about its ability to continue as a going concern. The pronouncement is effective for annual reporting periods ending after December 15, 2016 with early adoption permitted. The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements.

INVENTORIES

INVENTORIES	12 Months Ended
	Dec. 31, 2014
INVENTORIES [Abstract]
INVENTORIES	NOTE 3:-     INVENTORIES
		December 31,
			2014		2013
	Raw materials	$	919	$	1,304
	Finished products (*)		1,780		3,048
		$	2,699	$	4,352
	(*)	Includes amounts of $ 1,208 and $ 2,109 for 2014 and 2013, respectively, with respect to inventory delivered to customers but for which revenue criteria have not been met yet.

OTHER_ACCOUNTS_RECEIVABLE_AND_

OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES	12 Months Ended
	Dec. 31, 2014
OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES [Abstract]
OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES	NOTE 4:-     OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES
		December 31,
			2014		2013
	Indirect taxes	$	27	$	82
	Government of Israel - OCS receivable		357		389
	Prepaid expenses and work in progress		738		2,328
	Advances to suppliers		26		151
	Others		263		142
		$	1,411	$	3,092

PROPERTY_AND_EQUIPMENT_NET

PROPERTY AND EQUIPMENT, NET	12 Months Ended
	Dec. 31, 2014
PROPERTY AND EQUIPMENT, NET [Abstract]
PROPERTY AND EQUIPMENT, NET	NOTE 5:-    PROPERTY AND EQUIPMENT, NET
	Composition of assets, grouped by major classification, is as follows:
		December 31,
			2014		2013
	Cost:
	Demonstration and rental equipment	$	16	$	4
	Research and development equipment		206		206
	Manufacturing equipment		149		149
	Office furniture and equipment		482		461
	Leasehold improvements		419		418
			1,272		1,238
	Accumulated depreciation:
	Demonstration and rental equipment		-		-
	Research and development equipment		179		146
	Manufacturing equipment		101		77
	Office furniture and equipment		393		378
	Leasehold improvements		399		384
			1,072		985
		$	200	$	253
	Depreciation expenses for the year ended December 31, 2014, 2013 and 2012 amounted to $ $87, $108 and $ 119, respectively. In addition, during the years ended December 31, 2014, and December 31, 2013 the Company recorded a reduction of $0 and $6,044 respectively to the cost, and accumulated depreciation of fully depreciated equipment no longer in use.

OTHER_ACCOUNTS_PAYABLE_AND_ACC

OTHER ACCOUNTS PAYABLE AND ACCRUED EXPENSES	12 Months Ended
	Dec. 31, 2014
OTHER ACCOUNTS PAYABLE AND ACCRUED EXPENSES [Abstract]
OTHER ACCOUNTS PAYABLE AND ACCRUED EXPENSES	NOTE 6:-     OTHER ACCOUNTS PAYABLE AND ACCRUED EXPENSES
		December 31,
		2014		2013
	Royalties - OCS payable	$	827	$	690
	Commissions		76		62
	Provision for product warranty		75		142
	Accrued expenses		761		901
		$	1,739	$	1,795

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2014
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 7:-    COMMITMENTS AND CONTINGENCIES
	a.      Royalty commitments:
	1.      The Company receives research and development grants from the OCS. In consideration for the research and development grants received from the OCS, the Company has undertaken to pay royalties as a percentage of revenues from products developed from research and development projects financed. If the Company will not generate sales of products developed with funds provided by the OCS, the Company is not obligated to pay royalties or repay the grants.
	Royalties are payable at the rate of 3.5% from the time of commencement of sales of all of these products until the cumulative amount of the royalties paid equals 100% of the dollar-linked amounts of the grants received, plus interest at LIBOR rate.
	The total research and development grants that the Company has received from the OCS as of December 31, 2014 were $36,685. The accumulated interest as of December 31, 2014 was $12,709. As of December 31, 2014, the accumulated royalties paid to the OCS were $10,918. Accordingly, the Company's total commitment with respect to royalty-bearing participation received or accrued, net of royalties paid or accrued, amounted to $38,476 as of December 31, 2014.
	Royalty expenses relating to the OCS grants included in cost of sales for the years ended December 31, 2014, 2013 and 2012 were $827, $706 and $562, respectively.
	In May 2010, the Company received a notice from the OCS regarding alleged miscalculations in the amount of royalties paid by the Company to the OCS for the years 1992-2009 and the revenues basis of which the Company has to pay royalties. The Company believes that all royalties due to the OCS from the sale of products developed with funding provided by the OCS during such years were properly paid or were otherwise accrued. During 2011, the Company reviewed with the OCS alleged miscalculation differences and since then await further instructions. The Company assessed the merits of the aforesaid arguments raised by the OCS and recorded liability for an estimated loss respectively.
	2.       According to the Company's agreements with the Israel-U.S Bi-National Industrial Research and Development Foundation ("BIRD-F"), the Company is required to pay royalties at a rate of 5% of sales of products developed with funds provided by the BIRD-F, up to an amount equal to 150% of BIRD-F's grant (linked to the United States Consumer Price Index) relating to such products. The last funds from the BIRD-F were received in 1996. In the event the Company does not generate sales of products developed with funds provided by BIRD-F, the Company is not obligated to pay royalties or repay the grants.
	The total research and development funds that the Company has received from the BIRD-F were $340. As of December 31, 2014, the Company is required to pay royalties up to an amount of $789, including linkage to the United States Consumer Price Index (CPI).
	As of December 31, 2014, the accumulated royalties paid to the BIRD-F including linkage to the CPI were $434. Accordingly, the Company's total commitment with respect to royalty-bearing participation received, net of royalties paid, amounted to $355 as of December 31, 2014.
	Starting 2003 the Company has not generated sales of products developed with the funds provided by BIRD-F, therefore the Company is not obligated to pay royalties or repay the grant since that date.
	3.      In April 2012, the Israeli Ministry of Economy, commerce and labor approved the Company's application for participation in funding the setting up of the Company's Indian subsidiary as part of a designated grants plan for the purpose of setting up and establishing a marketing agency in India. The grant is intended to cover up to 50% from the costs of the office establishment, logistics expenses and hiring employees and consultants in India, based on the approved budget for the plan over a period of 3 years.
	The Company is obligated to pay to the Israeli Ministry of Economy, commerce and labor royalties of 3% on sales in the target market over a period of five years but not more than the total linked amount of the grant received.
	The total marketing grants that the Company has received from the Ministry of Economy, commerce and labor as of December 31, 2014 were in the amount of $314. As of December 31, 2014, no liability was accrued.
	b.      Operating leases:
	Premises occupied by the Company and its subsidiaries are rented under various rental agreements, part of which are with related parties (see also Note 11). The rental agreements for the premises of the Company and its subsidiaries expire up to November 14, 2017.
	Aggregate minimum rental payments under non-cancelable operating leases as of December 31, 2014, are (in the aggregate) and for each succeeding fiscal year below:
	As of December 31, 2014:
	2015	$	601
	2016		519
	2017		523
	Total	$	1,643
	Total lease expenses (net of sublease income from premises under sublease agreements) amounted to $883, $941 and $1,056 for the years ended December 31, 2014, 2013 and 2012, respectively.
	c.      Bank guarantee:
	As of December 31, 2014, the Company established a guarantee to the Israeli customs amounted to $ 32 which expires on April 30, 2015.
	d.      Pledge:
	The Company pledged and granted to a commercial bank a first priority floating charge on all of our assets, and a first priority fixed charge on certain other assets in connection to various services received from time to time from the commercial bank. The Pledge contains a number of customary restrictive terms and covenants that limit the Company operating flexibility, such as (1) limitations on the creation of additional liens and on the sale or transfer of certain Company assets, and (2) the ability of the bank to accelerate repayment upon the occurrence of certain events, such as breach of covenants, liquidation, or a reduction in joint ownership of certain principal shareholders of the Company below 30% or the equity below 32% with respect to the balance sheet's total. As of December 31, 2014, the Company has no financial obligations. In addition, as of the date of the consolidated financial statements the Company met all of the requirements of the restrictive terms and covenants of the pledge and expects to continue to meet them in the foreseeable future.

TAXES_ON_INCOME

TAXES ON INCOME	12 Months Ended
	Dec. 31, 2014
TAXES ON INCOME [Abstract]
TAXES ON INCOME	NOTE 8:-    TAXES ON INCOME
	a.      Israeli taxation:
	Taxable income of the Israeli parent is subject to the Israeli corporate tax at the rate as follows: 2012 - 25%, 2013- 25%.
	On July 30, 2013 the Israeli Parliament (the Knesset) passed a law which was designated to increase the tax levy in the years 2013 and 2014. Among other, the law increases the Israeli corporate tax rate from 25% to 26.5%.
	The Company has not received final tax assessments since incorporation. In accordance with the tax laws, tax returns submitted up to and including the 2009 tax year can be regarded as final.
	Tax loss carryforward:
	As of December 31, 2014, the Company's tax loss carryforward and capital loss were $ 36,619 and $ 633, respectively. Such losses can be carried forward indefinitely to offset any future taxable income of the Company.
	b.      Foreign subsidiaries:
	U.S subsidiary:
	1.      The U.S subsidiary is taxed under United States federal and state tax rules.
	2.     The U.S subsidiary's tax loss carryforward amounted to $8,516 as of December 31, 2014 for federal and state tax purposes. Such losses are available to offset any future U.S taxable income of the U.S subsidiary and will expire in the years 2014-2027 for federal tax purpose and in the year 2014 for state tax purpose.
	3.      The U.S subsidiary has not received final tax assessments since incorporation. In accordance with the tax laws, tax returns submitted up to and including the 2010 tax year can be regarded as final.
	Brazilian subsidiary:
	1.      The Brazilian subsidiary is taxed under Brazilian tax rules.
	2.      The Brazilian subsidiary's tax loss carryforward amounted to $742 as of December 31, 2014 for tax purposes. Tax losses may be carried forward indefinitely, but can only offset up to 30% of the company taxable income for a tax period.
	c.      Deferred taxes:
	Deferred taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and for tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows:
			31-Dec
			2014				2013
	Deferred tax assets:
	Carryforward tax losses		$	14,781			$	16,638
	Research and development credit			513				635
	Accrued social benefits and other			767				1,114
				16,061				18,387
	Less - valuation allowance			(16,061	)			(18,387	)
	Net deferred tax assets		$	-			$	-
	The net change in the total valuation allowance for the year ended December 31, 2014 was an decrease of $2,326 and is mainly relates to decrease in deferred taxes on NOL's for which a full valuation allowance was recorded. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets depends on the generation of future taxable income during the periods in which those temporary differences and tax loss carryforward are deductible. Management considers the projected taxable income and tax-planning strategies in making this assessment. In consideration of the Company's accumulated losses and the uncertainty of its ability to utilize its deferred tax assets in the future, management currently believes that it is more likely than not that the Company will not realize its deferred tax assets and accordingly recorded a valuation allowance to fully offset all the deferred tax assets.
	d.      Taxes on income are comprised from withholding taxes that were deducted by the Company's clients.
	e.      The components of income (loss) before income taxes are as follows:
		Year ended December 31,
		2014				2013				2012
	Domestic	$	3,350			$	(1,618	)		$	(5,684	)
	Foreign		-2,444				198				(183	)
	Income (loss) before income taxes	$	906			$	(1,420	)		$	(5,867	)
	f.      Reconciliation of the theoretical tax benefit and the actual tax expense:
		Year ended December 31,
		2014				2013				2012
	Income (loss) before income taxes, as reported in the statements of operations	$	906			$	(1,420	)		$	(5,867	)
	Statutory tax rate in Israel		26.5	%			25	%			25	%
	Theoretical tax benefit	$	240			$	(355	)		$	(1,467	)
	Increase (decrease) in income taxes resulting from:
	Tax rate differential on foreign subsidiaries		-176				19				(11	)
	Non-deductible expenses and other permanent differences		222				165				185
	Change of deferred tax as result of tax rate change		-				(727	)			-
	Utilization of tax losses in respect of which deferred tax assets were not recorded in prior years		-				(469	)			-
	Differences in taxes arising from differences between Israeli currency income and dollar income, net		1,715				186
	Losses and timing differences for which no deferred taxes were recorded		-2,326				1,619				1,083
	withholding taxes that were deducted by the Company's clients		180								120
	Other		325				(438	)			210
	Income taxes	$	180			$	-			$	120
	g.      Accounting for uncertainty in income taxes:
	For the years ended December 31, 2014, 2013 and 2012, the Company did not have any unrecognized tax benefits and no interest and penalties related to unrecognized tax benefits had been accrued. The Company does not expect that the amount of unrecognized tax benefits will change significantly within the next 12 months.

SHAREHOLDERS_EQUITY

SHAREHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2014
SHAREHOLDERS' EQUITY [Abstract]
SHAREHOLDERS' EQUITY	NOTE 9:-     SHAREHOLDERS' EQUITY
	a.         The number of shares issued and outstanding at December 31, 2014 and 2013 does not include 5,189 Ordinary Shares, which are held by a subsidiary, and 30,843            Ordinary Shares which are held by the Company.
	1.         Ordinary Shares confer all rights to their holders, e.g. voting, equity and receipt of dividend.
	2.        On April 24, 2013, the Company entered into a private placement transaction (the "2013 PIPE"). Under the 2013 PIPE investment, the Company issued 1,239,639 Ordinary Shares to existing and new investors (investors in the 2013 PIPE included certain existing shareholders) at an aggregate gross purchase price of $ 3,459 or $ 2.79 per Ordinary Share. The related issuance costs amounted to $35. The Company also issued to the investors warrants to purchase one Ordinary Share for every three Ordinary Shares purchased by each investor (up to 413,213 shares) for an exercise price of $ 3.49 per Ordinary Share and therefore were recorded and classified as part of shareholders' equity. The warrants are exercisable for three years from the closing of the 2013 PIPE. As of December 31, 2014, 79,307 warrants were exercised.
	b.         Share option plans:
	1.         The Company has granted options under option plans as follows:
	Under the following plans options are granted for periods not to exceed seven years. Options vest over a period of zero to four years from date of grant. Any options that are cancelled or forfeited before expiration become available for future grants.
	a)         The 2003 Share Option Plan:
	The 2003 Share Option Plan (the "2003 Share Option Plan") grants options to purchase Ordinary Shares. These options are granted pursuant to the 2003 Share Option Plan for the purpose of providing incentives to employees, directors, consultants and contractors of the Company. In accordance with Section 102 of the Income Tax Ordinance (New Version) - 1961, the Company's Board of Directors (the "Board") elected the "Capital Gains Route". The plan expired on December 21, 2012 for future grants.
	b)         The 2013 Share Option Plan:
	On April 3, 2013, the Company approved a new Share Option Plan (the "2013 Share Option Plan"). The 2013 Share Option Plan grants options to purchase Ordinary Shares. These options are granted pursuant to the 2013 Share Option Plan for the purpose of providing incentives to employees, directors, consultants and contractors of the Company. In accordance with Section 102 of the Income Tax Ordinance (New Version) - 1961, the Company's Board of Directors (the "Board") elected the "Capital Gains Route" (See also note 12).
	2.       Grants in 2014, 2013 and 2012 were at exercise prices equal to the market value of the Ordinary Shares at the date of grant.
	3.       Stock options under the Radcom plans are as follows for the periods indicated:
											Weighted - average
			Number of								remaining
			options(in				Weighted - average				contractual term		Aggregate
			thousands)				exercise price				(in years)		intrinsic value
	Outstanding at January 1, 2014			1,013,492				4.34				3.64	$	1,813
	Granted			282,000				5.85
	Exercised			(493,993	)			3.44
	Expired & forfeited			(35,374	)			6.41
	Outstanding at December 31, 2014			766,125				5.38				3.55	$	5,221
	Vested and expected to vest at December 31, 2014			766,125				5.38				3.55	$	5,221
	Exercisable at December 31, 2014			588,525				5.33				3.21	$	4,050
	The aggregate intrinsic value of options outstanding at December 31, 2014 represents intrinsic value of 721,475 outstanding options that are in-the-money as of December 31, 2014. The remaining 44,650 outstanding options are out of the money as of December 31, 2014, and their intrinsic value was considered as zero.
	The aggregate intrinsic value of options exercisable at December 31, 2014 represents intrinsic value of 544,225 outstanding options that are in-the-money as of December 31, 2014. The remaining 44,300 outstanding options are out of the money as of December 31, 2014, and their intrinsic value was considered as zero.
	During the year ended December 31, 2014, the Company's Board of Directors approved the grant of 282,000 to certain grantees at an exercise price ranged among $5.25 to $8.60 per share. Such options have vesting schedule of one year since the grant date.
	The total number of shares available for future grants under the 2013 Share Option Plan as of December 31, 2014 was 24,000. On Feb 2015, the Board of Directors authorized additional 250,000 options for future grants.
	4.       As of December 31, 2014, stock options under the Radcom 2003 Share Option Plan and 2013 Share Option Plan are as follows for the periods indicated:
		Options outstanding					Options exercisable
		at December 31, 2014
							at December 31, 2014
	Exercise price	Number outstanding		Weighted average exercise price		Weighted average remaining contractual life	Number exercisable		Weighted average exercise price	Weighted average remaining contractual life
	$			$		In years			$	In years
	0.7 - 1.95	58,150		1.83		1.98	58,150		1.83	1.98
	2.56 - 4.86	345,700		3.5		3.82	305,700		3.55	3.69
	5.0 - 8.60	257,125		6.07		4.12	119,875		5.9	3.57
	10.80 - 13.16	105,150		11.81		2.1	104,800		11.8	2.1
		766,125					588,525
	5.       The weighted average fair values of options granted during the years ended December 31, 2014, 2013 and 2012 were $2.7, $1.7 and $2.5, respectively.
	6.       The following table summarizes the departmental allocation of the Company's share-based compensation charge:
			Year ended December 31,
			2014				2013				2012
	Cost of sales		$	12			$	7			$	14
	Research and development			178				117				205
	Selling and marketing			146				82				167
	General and administrative			243				293				286
			$	579			$	499			$	672
	7.       Share-based compensation:
	As of December 31, 2014, there are $220 of total unrecognized company cost related to non-vested share based compensation that are expected to be recognized over a period of up to 2 years.
	c.         Warrants:
	The Company's outstanding warrants and rights as of December 31, 2014 are as follows:
	Issuance date	Outstanding and exercisable		Exercise price		Exercisable through
	24-Apr-13	333,906		3.49		23-Apr-16

SELECTED_STATEMENTS_OF_OPERATI

SELECTED STATEMENTS OF OPERATIONS DATA	12 Months Ended
	Dec. 31, 2014
SELECTED STATEMENTS OF OPERATIONS DATA [Abstract]
SELECTED STATEMENTS OF OPERATIONS DATA	NOTE 10:-     SELECTED STATEMENTS OF OPERATIONS DATA
	a.        The Company applies ASC topic 280, "Segment Reporting", ("ASC 820"). The Company operates in one reportable segment (see also Note 1 for a brief description of the Company's business). The total revenues are attributed to geographic areas based on the location of the end customer.
	b.        The following table present total revenues for the years ended December 31, 2014, 2013 and 2012 and long-lived assets as of December 31, 2014, 2013 and 2012:
	1. Revenues from sales to unaffiliated customers:
		Year ended December 31,
		2014			2013				2012
	North America	$	1,922		$	1,687			$	3,850
	Europe		3,189			4,044				2,970
	Asia (Excluding Philippines)		847			435				1,534
	Philippines		3,544			3,173				1,292
	South America (Excluding Brazil)		4,235			4,579				2,848
	Brazil		6,448			5,469				1,896
	Other (Including Israel)		3,451			1,095				1,396
		$	23,636		$	20,482			$	15,786
	2.       Property and equipment, net, by geographic areas:
		Year ended December 31,
		2014			2013				2012
	Israel	$	151		$	213			$	222
	Other		49			40				46
		$	200		$	253			$	268
	3.       Major customer data as a percentage of total revenues:
	In 2014, the Company had three customers in the Brazil, Philippines and Israel that amounted 22.2%, 14.9% and 11.7%, respectively, of the total consolidated revenues. In 2013, the Company had two customers in the Philippines and Brazil that amounted 15.5% and 10.7%, respectively, of the total consolidated revenues. During 2012, the Company did not have any customer that amounted to more than 10% of the total respective consolidated revenues.
	c.        Financial expenses, net:
		Years ended December 31,
		2014			2013				2012
	Financial Income:
	Interest income	$	170		$	49			$	15
	Foreign currency exchange gain		193			36				77
			363			85				92
	Financial expenses:
	Interest and bank charges		(40	)		(117	)			(108	)
	Foreign currency exchange gain		(655	)		(259	)			(298	)
			(695	)		(376	)			(406	)
		$	(332	)	$	(291	)		$	(314	)
	d.        Net income (loss) per share:
	The following table sets forth the computation of basic and diluted net income (loss) per share:
		Years ended December 31,
		2014			2013			2012
	Numerator:
	Numerator for basic net income (loss) per share	$	726		$	(1,420	)	$	(5,987	)
	Effect of dilutive securities:
	Option and warrants issued to grantees and investors, respectively		-			-			-
	Numerator for dilutive net income (loss) per share	$	726		$	(1,420	)	$	(5,987	)
	Denominator:
	Denominator for dilutive net income (loss) per share - weighted average number of ordinary share		8,088,974			7,340,056			6,442,068
	Effect of dilutive securities:
	Option and warrants issued to grantees and investors, respectively		503,413			-			-
	Denominator for diluted net income (loss) per share - adjusted weighted average number of ordinary share		8,592,387			7,340,056			6,442,068

RELATED_PARTY_BALANCES_AND_TRA

RELATED PARTY BALANCES AND TRANSACTIONS	12 Months Ended
	Dec. 31, 2014
RELATED PARTY BALANCES AND TRANSACTIONS [Abstract]
RELATED PARTY BALANCES AND TRANSACTIONS	NOTE 11:-     RELATED PARTY BALANCES AND TRANSACTIONS
	a.       The Company carries out transactions with related parties as detailed below. Certain principal shareholders of the Company which as of December 31, 2014 have joint ownership of approximately 38% in the Company's equity are also principal shareholders of affiliates known as the RAD-BYNET Group. The Company's transactions with related parties are carried out on an arm's-length basis.
	1.     Certain premises occupied by the Company and the US subsidiary are rented from related parties (see also Note 7b). The US subsidiary also sub-leases certain premises to a related party. The aggregate net amounts of lease payments were $ 417, $ 410 and $ 438 in 2014, 2013 and 2012, respectively.
	2.      Certain entities within the RAD-BYNET Group provide the Company with administrative services. Such amounts expensed by the Company are disclosed in "d" below as "Cost of sales, Sales and marketing, General and administrative expenses and research and development".
	3.       The Company purchases from certain entities within the RAD-BYNET Group software packages included in the Company's products and is thus incorporated into certain of its product lines. Such purchases by the Company are disclosed in "d" as "Cost of sales and Research and development".
	4.       The Company was a party to a distribution agreement with Bynet Electronics Ltd. ("BYNET"), a related party, giving BYNET the exclusive right to distribute the Company's products in Israel. The agreement was terminated during 2013.
	Revenues related to this distribution agreement are included in "d" below as "revenues". The remainder of the amount of "revenues" included in "d" below is comprised of sales of the Company's products to entities within RAD-BYNET Group.
	b.   In December 2012, the Company entered into a consulting agreement ("Agreement") with a consultant which is also the domestic partner of one of its controlling shareholders and Chairman of the Company's Board of Directors. Based on the key terms of the Agreement, the consultant provided advisory services to the management with respect to business operations for a monthly amount which equaled the average monthly salary of employees in Israel, plus Israeli Value Added Tax.  The Agreement was expired in January 2013 but was extended through to January 2015. Expenses incurred under this Agreement are immaterial. During the years ended December 31, 2014, 2013 and 2012 the Company recorded expenses incurred under this Agreement in amount of $ 39, $ 43 and $ 37, respectively.
	c.       In November 2012, the Company secured a loan of $ 750 (equivalent to 2,900 NIS at that time) from one of its principal shareholder and Chairman of the Company's Board of Directors to finance its operations. The term of the loan was initially until March 31, 2013 which was extended until June 30, 2013. The loan was exposed to changes in the USD/NIS exchange rates. The loan was fully repaid by the Company during June 2013. The loan was interest-free, but the amount of principal required to be repaid was linked to the Israeli CPI. The average Israeli CPI increased during the years ended December 31, 2012 and 2013, by 1.6% and 1.8% respectively which caused finance expenses amounted to $ 23 and $ 27 for the aforementioned years, respectively.
	d.       Following to Note 9a2, in April and June 2013, the Company completed 2013 PIPE in which $ 3,459 have been raised from certain existing and new investors, including $ 1,100 and $ 50 were invested by one of its principal shareholder and Chairman of the Company's Board of Directors and the Company's President and Chief Executive Officer, respectively.
	e.        Balances with related parties:
		December 31,
		2014		2013
	Assets:
	Trade receivables	$	2	$	11
	Other accounts receivable and prepaid expenses	$	-	$	-
	Liabilities:
	Trade Payables	$	155	$	159
	Other accounts payables and accrued expenses	$	11	$	46
	f.      Transactions with related parties:
		Year ended December 31,
		2014		2013		2012
	Revenues	$	19	$	403	$	451
	Expenses:
	Cost of sales	$	56	$	54	$	66
	Operating expenses:
	Research and development	$	249	$	208	$	198
	Sales and marketing	$	125	$	126	$	181
	General and administrative	$	60	$	53	$	57
	Financial expenses (income)	$	-	$	27	$	23

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2014
SUBSEQUENT EVENTS [Abstract]
SUBSEQUENT EVENTS	NOTE 12:-     SUBSEQUENT EVENTS
	a.        On February 2, 2015, our Board of Directors resolved to increase the number of outstanding shares reserved under the 2013 Share Option Plan, from 500,000 to 750,000.
	In addition, On February 2, 2015, the Board of Directors approved the grant of 191,750 (10,000 out of which are subject to shareholders approval) options to certain Company's employees and officers.  The options shall vest in one year, over four equal quarterly installments, commencing as of the effective date of the grant.
	b.        On February 19, 2015, the Company's Board of Directors amended the Company's 2013 Stock Option Plan. The 2013 Plan expires on April 2, 2023. Under the amended 2013 Plan, the Company may in addition to granting options to purchase its ordinary shares, also grant restricted shares and Restricted Share Units ("RSUs") to its employees, directors, consultants and contractors.

SIGNIFICANT_ACCOUNTING_POLICIE1

SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2014
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Use of estimates	a.       Use of estimates:
	The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Financial statements in U.S. dollars ("dollar" or "dollars")	b.       Financial statements in U.S. dollars ("dollar" or "dollars"):
	Most of the Company's and its subsidiaries, other than in Brazil, revenues and costs are denominated in U.S. dollars. Therefore, the Company's management believes the currency of the primary economic environment in which the operations of the Company are conducted is the United States dollar, which is used as the functional currency of the Company.
	Transactions and balances originally denominated in dollars are presented at their original amounts. Transactions and balances in other currencies are re-measured into dollars in accordance with the principles set forth in Statement of Accounting Standards Codification ("ASC") 830 "Foreign Currency Matters".
	Other than in the Company's subsidiary in Brazil, all exchange gains and losses from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the consolidated statement of operations when they arise.
	Amounts in the financial statements representing the dollar equivalent of balances denominated in other currencies do not necessarily represent their real or economic value and such amounts may not necessarily be exchangeable for dollars.
	For the Company's subsidiary in Brazil whose functional currency has been determined to be their local currency, assets and liabilities are translated at year-end exchange rates and statements of income items are translated at average exchange rates prevailing during the year. Such translation adjustments are recorded as a separate component of accumulated other comprehensive loss in shareholders' equity.
Principles of consolidation	c.       Principles of consolidation:
	The consolidated financial statements include the financial statements of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Cash equivalents	d.       Cash equivalents:
	The Company considers all highly liquid deposit instruments with an original maturity of three months or less at the date of purchase to be cash equivalents.
Restricted cash	e.       Restricted cash:
	Restricted cash is invested in a bank deposit, which is pledged in favor of the bank that provides guarantees to the Company.
Concentration of credit risk	f.       Concentration of credit risk:
	Financial instruments that may subject the Company to significant concentration of credit risk consist mainly of cash and cash equivalents severance pay fund and trade receivables.
	Cash and cash equivalents and are maintained with major financial institutions mainly in Israel. Assets held for severance benefits are maintained with major insurance companies and financial institutions in Israel. Such deposits are not insured. However, management believes that such financial institutions are financially sound and, accordingly, low credit risk exists with respect to these investments.
	The Company grants credit to customers without generally requiring collateral or security. The risk of collection associated with trade receivables is reduced by geographical dispersion of the Company's customer base. The Company establishes an allowance for doubtful accounts based on historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer's ability to pay. Allowance for doubtful accounts amounted to $0 and $20 thousand as of December 31, 2014 and 2013. The Company charges off receivables when they are deemed uncollectible. Actual collection experience may not meet expectations and may result in increased bad debt expense. No bad debt expenses have been recorded during the years ended December 31, 2014, 2013 and 2012. Total write-offs during the years ended December 31, 2014, 2013 and 2012 amounted to $0, $0 and $206, respectively.
Inventories	g.       Inventories:
	Inventories are stated at the lower of cost or market value. Cost is determined on a "moving average" basis. Inventory write-downs are provided to cover technological obsolescence, excess inventories and discontinued products.
	Inventory write-down is measured as the difference between the cost of the inventory and market based upon assumptions about future demand, and is charged to the cost of sales. At the point of the loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
	Total inventory write-offs during the years ended December 31, 2014, 2013 and 2012 amounted to $187, $110 and $311, respectively. Following to Note 1b, during the year ended December 31, 2014, the Company recorded additional inventory write-off amounted to $1,005.
Property and equipment	h.       Property and equipment:
	Property and equipment are stated at cost less accumulated depreciation. Maintenance and repairs are charged to operations as incurred.
	Depreciation is calculated on the straight-line method over the estimated useful lives of the assets.
	Annual rates of depreciation are as follows:
		%
	Research and development equipment	25 - 33
	Manufacturing equipment	15 - 33
	Office furniture and equipment	Jul-33
	Leasehold improvements	At the shorter of the lease period or useful life of the leasehold improvement
Impairment of long-lived assets	i.       Impairment of long-lived assets:
	The Company's long-lived assets are reviewed for impairment in accordance with ASC 360 "property, plants and equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of an asset to be held and used is assessed by a comparison of the carrying amount of the asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. During the years ended December 31, 2014, 2013 and 2012, no impairment losses were identified.
Revenue recognition	j.       Revenue recognition:
	Revenues from sales of products are recognized in accordance with ASC No. 605, "Revenue Recognition" when persuasive evidence of an agreement exists, delivery of the product has occurred, the fee is fixed or determinable and collectability is probable.
	Products are typically considered delivered upon shipment. In instances where final acceptance of the product is specified by the customer, and the acceptance is deemed substantive, revenue is deferred until all acceptance criteria have been met. The Company's arrangements generally do not include any provisions for cancellation, termination, or refunds that would significantly impact recognized revenue.
	The Company's revenues are generated from sales to independent distributors and direct customers. The Company has a contract that is standard in substance with its distributors. Based on this contract, sales to distributors are final and distributors have no rights of return or price protection. The Company is not a party to the agreements between distributors and their customers, however the Company recognizes its revenue on a "sale through" basis and therefore revenues from these distributors are deferred until all revenue recognition criteria of the sale to the end customer are met.
	The Company also generates sales through independent representatives. These representatives do not hold any of the Company's inventories, and they do not buy products from the Company. The Company invoices the end-user customers directly, collects payment directly and then pays commissions to the representative for the sales in its territory.
	Revenues in arrangements with multiple deliverables are allocated using the relative selling price method. The selling price for each deliverable is based on vendor-specific objective evidence ("VSOE") if available, third-party evidence ("TPE") if VSOE is not available, or estimated selling price ("ESP") if neither VSOE or TPE is available. The Company determines the BESP based on management estimated selling price by considering several external and internal factors including, but not limited to, pricing practices including discounting, margin objectives, and competition.
	Revenues from fixed price contracts that require significant customization, integration and installation are recognized based on ASC 605-35, "Construction-Type and Production-Type Contracts", using the percentage-of-completion method of accounting based on the ratio of costs related to contract performance incurred to date to the total estimated amount of such costs. The amount of revenue recognized is based on the total fees under the arrangement and the percentage of completion achieved. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are first determined, in the amount of the estimated loss on the entire contact. During the year ended December 31, 2014, the Company recognized revenue amounted to $2,205 from one contract which reflects completion percentage of 78%.
	Under the Company's selling arrangements, the Company provides a one-year warranty, which includes bug fixing and a hardware warranty ("Warranty") for all of its products. Accordingly, the Company records an appropriate provision for Warranty in accordance with ASC 450 "Contingencies" (see also Note 2m). After the Warranty period initially provided with the Company's products, the Company may sell extended warranty contracts on a standalone basis, which includes bug fixing and a hardware warranty. Revenue related to extended warranty contracts is recognized pursuant to ASC 605-20-25, "Separately Priced Extended Warranty and Product Maintenance Contracts." Pursuant to this provision, revenue related to separately priced product maintenance contracts is deferred and recognized over the term of the maintenance period.
	Deferred revenues represent unrecognized fees collected for extended warranty services.
Cost of revenues	k.       Cost of revenues:
	Cost of products is comprised of cost of hardware production, employees' salaries and related costs, allocated overhead expenses, warranty expenses, shipping and handling costs, sub-contractors costs, recurring and nonrecurring inventory and indirect taxes write-off, packaging, import taxes, license fees paid to third parties and royalties paid to the Office of the Chief Scientist (the "OCS").
	Cost of services is comprised of cost of hardware maintenance and customer support employees' salaries and related costs.
Share-based compensation	l.       Share-based compensation:
	The Company accounts for share-based compensation in accordance with ASC 718 which requires companies to estimate the fair value of share-based payment awards on the grant date using an option-pricing model.
	The Company recognizes compensation expenses for the value of its awards granted based on the accelerated attribution method over the requisite service period of each of the awards, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Estimated forfeitures are based on actual historical pre-vesting forfeitures.
	The Company selected the Black-Scholes option pricing model as the most appropriate fair value method for its stock-options awards. The option-pricing model requires a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected volatility was calculated based upon actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected option term. Expected term is calculated based on the simplified method as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term to the expected life of the options. Historically the Company has not paid dividends and in addition has no foreseeable plans to pay dividends, and therefore use an expected dividend yield of zero in the option pricing model.
	The fair value for options granted in 2014, 2013 and 2012 is estimated at the date of grant with the following weighted average assumptions:
			2014		2013		2012
	Dividend yield			0%		0%		0%
	Expected volatility			70%-74%		74%		80-100%
	Risk-free interest			0.6%-0.8%		0.3%-0.6%		0.3-0.4%
	Expected life (in years)			2.81		2.81		1.5-5.5
Provision for product warranty	m.      Provision for product warranty:
	The Company's policy is to grant a product warranty for a period of up to 12 months on its products. An extended warranty may be purchased for a longer period. The provision for warranties for all periods through December 31, 2014, is determined based upon the Company's past experience. As of December 31, 2014, the provision for product warranty is immaterial.
Research and development costs	n.       Research and development costs:
	Research and development costs are charged to statement of operations as incurred. ASC 985-20 "Software - Costs of Computer Software to be Sold, Leased or Otherwise Marketed", requires capitalization of certain software development costs subsequent to the establishment of technological feasibility.
	Based on the Company's product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company between completion of the working models and the point at which the products are ready for general release has been insignificant. Therefore, all research and development costs have been expensed.
Government grants	o.       Government grants:
	The Company receives royalty-bearing participation, which represents participation of the Government of Israel (specifically from the OCS) in approved programs for research and development. These amounts are recognized on the accrual basis as a reduction in research and development costs as such costs are incurred. Royalties to the OCS are recorded under cost of sales, when the related sales are recognized. See also Note 7a.
	The Company received participation from the Israeli Ministry of Economy, commerce and labor, which is a participation of up to 50% of relevant marketing expenses. These grants are presented as a reduction in marketing expenses amounted to $55, $150 and $109 for the years ended December 31, 2014, 2013 and 2012, respectively. See also Note 7a.
Income (loss) per share	p.       Income (loss) per share:
	Basic and diluted income (loss) per Ordinary Share of the Company ("Ordinary Shares") are presented in conformity with ASC 260 "Earnings Per Share", for all years presented. Basic income (loss) per Ordinary Share is computed by dividing net income (loss) for each reporting period by the weighted average number of Ordinary Shares outstanding during the period. Diluted income (loss) per Ordinary Share is computed by dividing net income (loss) for each reporting period by the weighted average number of Ordinary Shares outstanding during the period plus any additional Ordinary Shares that would have been outstanding if potentially dilutive securities had been exercised during the period, calculated under the treasury stock method.
	Certain securities were not included in the computation of diluted income (loss) per share since they were anti-dilutive. The total weighted average number of shares related to the outstanding options and warrants excluded from the calculation of diluted net income (loss) per share was 1,368,220, 1,353,372 and 1,248,631 as of December 31, 2014, 2013 and 2012, respectively.
Income taxes	q.       Income taxes:
	The Company accounts for income taxes in accordance with ASC 740 "Income Taxes". Deferred tax asset and liability account balances are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss and tax credit carryforward. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statement of operations in the period that includes the enactment date. The Company provides a full valuation allowance to reduce deferred tax assets to the extent it believes is more likely than not that such benefits will not be realized.
Income tax uncertainties	r.       Income tax uncertainties:
	In accordance with ASC 740 "Income Taxes", the Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. When applicable, the Company accounts for interest and penalties related to unrecognized tax benefits as a component of income tax expense.  As of December 31, 2014 and 2013, no liability for unrecognized tax benefits was recorded as a result of the implementation of ASC 740.
Severance pay	s.       Severance pay:
	The Company's liability for severance pay for its Israeli employees is calculated pursuant to Israeli severance pay law based on the most recent salary of the employees multiplied by the number of years of employment as of the balance sheet date. After completing one full year of employment, the Company's Israeli employees are entitled to one month's salary for each year of employment or a portion thereof. The Company's liability is partially provided by monthly deposits with severance pay funds, insurance policies and by an accrual. The liability for employee severance pay benefits included on the balance sheet represents the total liability for such severance benefits, while the assets held for severance benefits included on the balance sheet represent the current redemption value of the Company's contributions made to severance pay funds and to insurance policies.
	The carrying value of deposited funds includes profits (losses) accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israeli severance pay law or labor agreements.
	Effective January 1, 2012, the Company's agreements with new employees in Israel are in accordance with section 14 of the Severance Pay Law - 1963 which provide that the Company's contributions to severance pay fund shall cover its entire severance obligation. Upon termination, the release of the contributed amounts from the fund to the employee shall relieve the Company from any further severance obligation and no additional payments shall be made by the Company to the employee. As a result, the related obligation and amounts deposited on behalf of such obligation are not stated on the balance sheet, as the Company is legally released from severance obligation to employees once the amounts have been deposited, and the Company has no further legal ownership on the amounts deposited.
	Severance expenses for the years ended December 31, 2014, 2013 and 2012 amounted to $527, $537 and $588, respectively.
Fair value of financial instruments	t.       Fair value of financial instruments:
	The financial instruments of the Company consist mainly of cash and cash equivalents, restricted bank deposits, trade receivables, trade and other accounts payable and accrued expenses. Due to the short-term nature of such financial instruments, their fair value approximates their carrying value.
Concentrations of business risk	u.       Concentrations of business risk:
	Although the Company generally uses standard parts and components for products, certain key components used in the products are currently available from only one source, and others are available from a limited number of sources. The Company believes that it will not experience delays in the supply of critical components in the future. If the Company experiences such delays and there is an insufficient inventory of critical components at that time, the Company's operations and financial results would be adversely affected.
	The Company relies on a limited number of independent manufacturers, some of which are small, privately held companies, to provide certain assembly services to its specifications. The Company does not have any long-term supply agreements with any third-party manufacturer. If the Company's assembly services are reduced or interrupted, the Company's business, financial condition and results of operations could be adversely affected until the Company is able to establish sufficient assembly services supply from alternative sources. Alternative manufacturing sources may not be able to meet the Company's future requirements, and existing or alternative sources may not continue to be available at favorable prices.
	The Company's revenues in any period generally have been, and may continue to be, derived from relatively small numbers of sales with relatively high average revenues per order. Therefore, the loss of any orders or delays in closing such transactions could have an adverse effect on the Company's operations and financial results.
Legal contingencies	v.       Legal contingencies:
	The Company is currently involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss.
Comprehensive loss	w.      Comprehensive loss:
	The Company accounts for comprehensive loss in accordance with ASC No. 220, "Comprehensive Income" which establishes standards for the reporting and displays of comprehensive loss and its components in a full set of general purpose financial statements.  Comprehensive loss generally represents all changes in stockholders' equity during the period except those resulting from investments by, or distributions to shareholders. The Company determined that its only item of other comprehensive loss relates to foreign currency translation adjustment and gains or losses on intra-entity foreign currency transactions that are of a long-term investment nature in connection to its subsidiary in Brazil.

SIGNIFICANT_ACCOUNTING_POLICIE2

SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2014
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Schedule of Annual Rates of Depreciation		%
	Research and development equipment	25 - 33
	Manufacturing equipment	15 - 33
	Office furniture and equipment	Jul-33
	Leasehold improvements	At the shorter of the lease period or useful life of the leasehold improvement
Assumptions Used in Estimation of Fair Value of Stock-based Compensation Awards			2014		2013		2012
	Dividend yield			0%		0%		0%
	Expected volatility			70%-74%		74%		80-100%
	Risk-free interest			0.6%-0.8%		0.3%-0.6%		0.3-0.4%
	Expected life (in years)			2.81		2.81		1.5-5.5

INVENTORIES_Tables

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2014
INVENTORIES [Abstract]
Schedule of Inventories
		December 31,
			2014		2013
	Raw materials	$	919	$	1,304
	Finished products (*)		1,780		3,048
		$	2,699	$	4,352
	(*)	Includes amounts of $ 1,208 and $ 2,109 for 2014 and 2013, respectively, with respect to inventory delivered to customers but for which revenue criteria have not been met yet.

OTHER_ACCOUNTS_RECEIVABLE_AND_1

OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES (Tables)	12 Months Ended
	Dec. 31, 2014
OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES [Abstract]
Schedule of Other Accounts Receivable And Prepaid Expenses		December 31,
			2014		2013
	Indirect taxes	$	27	$	82
	Government of Israel - OCS receivable		357		389
	Prepaid expenses and work in progress		738		2,328
	Advances to suppliers		26		151
	Others		263		142
		$	1,411	$	3,092

PROPERTY_AND_EQUIPMENT_NET_Tab

PROPERTY AND EQUIPMENT, NET (Tables)	12 Months Ended
	Dec. 31, 2014
PROPERTY AND EQUIPMENT, NET [Abstract]
Composition of Assets, Grouped by Major Classification		December 31,
			2014		2013
	Cost:
	Demonstration and rental equipment	$	16	$	4
	Research and development equipment		206		206
	Manufacturing equipment		149		149
	Office furniture and equipment		482		461
	Leasehold improvements		419		418
			1,272		1,238
	Accumulated depreciation:
	Demonstration and rental equipment		-		-
	Research and development equipment		179		146
	Manufacturing equipment		101		77
	Office furniture and equipment		393		378
	Leasehold improvements		399		384
			1,072		985
		$	200	$	253

OTHER_ACCOUNTS_PAYABLE_AND_ACC1

OTHER ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	12 Months Ended
	Dec. 31, 2014
OTHER ACCOUNTS PAYABLE AND ACCRUED EXPENSES [Abstract]
Schedule of Other Accounts Payable and Accrued Expenses		December 31,
		2014		2013
	Royalties - OCS payable	$	827	$	690
	Commissions		76		62
	Provision for product warranty		75		142
	Accrued expenses		761		901
		$	1,739	$	1,795

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2014
COMMITMENTS AND CONTINGENCIES [Abstract]
Schedule Of Future Minimum Rental Payments	As of December 31, 2014:
	2015	$	601
	2016		519
	2017		523
	Total	$	1,643

TAXES_ON_INCOME_Tables

TAXES ON INCOME (Tables)	12 Months Ended
	Dec. 31, 2014
TAXES ON INCOME [Abstract]
Significant Components of Deferred Tax Assets and Liabilities			31-Dec
			2014				2013
	Deferred tax assets:
	Carryforward tax losses		$	14,781			$	16,638
	Research and development credit			513				635
	Accrued social benefits and other			767				1,114
				16,061				18,387
	Less - valuation allowance			(16,061	)			(18,387	)
	Net deferred tax assets		$	-			$	-
Components of Income (Loss) Before Income Taxes		Year ended December 31,
		2014				2013				2012
	Domestic	$	3,350			$	(1,618	)		$	(5,684	)
	Foreign		-2,444				198				(183	)
	Income (loss) before income taxes	$	906			$	(1,420	)		$	(5,867	)
Reconciliation of Theoretical Tax Benefit and Actual Tax Expense		Year ended December 31,
		2014				2013				2012
	Income (loss) before income taxes, as reported in the statements of operations	$	906			$	(1,420	)		$	(5,867	)
	Statutory tax rate in Israel		26.5	%			25	%			25	%
	Theoretical tax benefit	$	240			$	(355	)		$	(1,467	)
	Increase (decrease) in income taxes resulting from:
	Tax rate differential on foreign subsidiaries		-176				19				(11	)
	Non-deductible expenses and other permanent differences		222				165				185
	Change of deferred tax as result of tax rate change		-				(727	)			-
	Utilization of tax losses in respect of which deferred tax assets were not recorded in prior years		-				(469	)			-
	Differences in taxes arising from differences between Israeli currency income and dollar income, net		1,715				186
	Losses and timing differences for which no deferred taxes were recorded		-2,326				1,619				1,083
	withholding taxes that were deducted by the Company's clients		180								120
	Other		325				(438	)			210
	Income taxes	$	180			$	-			$	120

SHAREHOLDERS_EQUITY_Tables

SHAREHOLDERS' EQUITY (Tables)	12 Months Ended
	Dec. 31, 2014
SHAREHOLDERS' EQUITY [Abstract]
Schedule of Stock Option Activity											Weighted - average
			Number of								remaining
			options(in				Weighted - average				contractual term		Aggregate
			thousands)				exercise price				(in years)		intrinsic value
	Outstanding at January 1, 2014			1,013,492				4.34				3.64	$	1,813
	Granted			282,000				5.85
	Exercised			(493,993	)			3.44
	Expired & forfeited			(35,374	)			6.41
	Outstanding at December 31, 2014			766,125				5.38				3.55	$	5,221
	Vested and expected to vest at December 31, 2014			766,125				5.38				3.55	$	5,221
	Exercisable at December 31, 2014			588,525				5.33				3.21	$	4,050
Stock Options Under the Plans by Exercise Price		Options outstanding					Options exercisable
		at December 31, 2014
							at December 31, 2014
	Exercise price	Number outstanding		Weighted average exercise price		Weighted average remaining contractual life	Number exercisable		Weighted average exercise price	Weighted average remaining contractual life
	$			$		In years			$	In years
	0.7 - 1.95	58,150		1.83		1.98	58,150		1.83	1.98
	2.56 - 4.86	345,700		3.5		3.82	305,700		3.55	3.69
	5.0 - 8.60	257,125		6.07		4.12	119,875		5.9	3.57
	10.80 - 13.16	105,150		11.81		2.1	104,800		11.8	2.1
		766,125					588,525
Departmental Allocation of Share-based Compensation Charge			Year ended December 31,
			2014				2013				2012
	Cost of sales		$	12			$	7			$	14
	Research and development			178				117				205
	Selling and marketing			146				82				167
	General and administrative			243				293				286
			$	579			$	499			$	672
Outstanding Warrants and Rights	Issuance date	Outstanding and exercisable		Exercise price		Exercisable through
	24-Apr-13	333,906		3.49		23-Apr-16

SELECTED_STATEMENTS_OF_OPERATI1

SELECTED STATEMENTS OF OPERATIONS DATA (Tables)	12 Months Ended
	Dec. 31, 2014
SELECTED STATEMENTS OF OPERATIONS DATA [Abstract]
Schedule of revenues from sales to unaffiliated customers		Year ended December 31,
		2014			2013				2012
	North America	$	1,922		$	1,687			$	3,850
	Europe		3,189			4,044				2,970
	Asia (Excluding Philippines)		847			435				1,534
	Philippines		3,544			3,173				1,292
	South America (Excluding Brazil)		4,235			4,579				2,848
	Brazil		6,448			5,469				1,896
	Other (Including Israel)		3,451			1,095				1,396
		$	23,636		$	20,482			$	15,786
Schedule of property and equipment, net, by geographic areas		Year ended December 31,
		2014			2013				2012
	Israel	$	151		$	213			$	222
	Other		49			40				46
		$	200		$	253			$	268
Schedule of Financial Expenses, Net		Years ended December 31,
		2014			2013				2012
	Financial Income:
	Interest income	$	170		$	49			$	15
	Foreign currency exchange gain		193			36				77
			363			85				92
	Financial expenses:
	Interest and bank charges		(40	)		(117	)			(108	)
	Foreign currency exchange gain		(655	)		(259	)			(298	)
			(695	)		(376	)			(406	)
		$	(332	)	$	(291	)		$	(314	)
Schedule of computation of basic and diluted net income (loss) per share		Years ended December 31,
		2014			2013			2012
	Numerator:
	Numerator for basic net income (loss) per share	$	726		$	(1,420	)	$	(5,987	)
	Effect of dilutive securities:
	Option and warrants issued to grantees and investors, respectively		-			-			-
	Numerator for dilutive net income (loss) per share	$	726		$	(1,420	)	$	(5,987	)
	Denominator:
	Denominator for dilutive net income (loss) per share - weighted average number of ordinary share		8,088,974			7,340,056			6,442,068
	Effect of dilutive securities:
	Option and warrants issued to grantees and investors, respectively		503,413			-			-
	Denominator for diluted net income (loss) per share - adjusted weighted average number of ordinary share		8,592,387			7,340,056			6,442,068

RELATED_PARTY_BALANCES_AND_TRA1

RELATED PARTY BALANCES AND TRANSACTIONS (Tables)	12 Months Ended
	Dec. 31, 2014
Balances With Related Parties [Member]
Related Party Transaction [Line Items]
Schedule of Related Parties		December 31,
		2014		2013
	Assets:
	Trade receivables	$	2	$	11
	Other accounts receivable and prepaid expenses	$	-	$	-
	Liabilities:
	Trade Payables	$	155	$	159
	Other accounts payables and accrued expenses	$	11	$	46
Transactions With Related Parties [Member]
Related Party Transaction [Line Items]
Schedule of Related Parties		Year ended December 31,
		2014		2013		2012
	Revenues	$	19	$	403	$	451
	Expenses:
	Cost of sales	$	56	$	54	$	66
	Operating expenses:
	Research and development	$	249	$	208	$	198
	Sales and marketing	$	125	$	126	$	181
	General and administrative	$	60	$	53	$	57
	Financial expenses (income)	$	-	$	27	$	23

GENERAL_Details

GENERAL (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Inventory [Line Items]
Write-off charge of inventory and related costs	$1,815	$110	$311
Accumulated deficit	-57,096	-57,822
Cash generated from operating activities	3,386	-2,130	-2,461
Costs of revenue [Member]
Inventory [Line Items]
Write-off charge of inventory and related costs	1,639
Selling and marketing [Member]
Inventory [Line Items]
Write-off charge of inventory and related costs	$176

SIGNIFICANT_ACCOUNTING_POLICIE3

SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	item
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Trade receivables, allowances for doubtful accounts	$0	$20
Bad debt expense	0	0	0
Additional inventory write-down	1,005
Bad debt write offs	0	0	206
Inventory write offs	1,815	110	311
Shares excluded from the calculation of diluted net income (loss) per share	1,368,220	1,353,372	1,248,631
Uncertain tax position, likelihood of being sustained, threshold for recognition	50.00%
Years employment required for eligibility for severance pay	1 year
Months severance salary payable per year of employment	1 month
Severance pay expenses	527	537	588
Number of suppliers of certain key components	1
Revenue from contract	2,205
Number of contract	1
Completion percentage of contract	78.00%
Percentage of marketing expenses for which entity receive grants	50.00%
Grants received presented as a reduction in marketing expenses	$55	$150	$109

SIGNIFICANT_ACCOUNTING_POLICIE4

SIGNIFICANT ACCOUNTING POLICIES (Annual Rates of Depreciation) (Details)	12 Months Ended
	Dec. 31, 2014
Research and development equipment [Member]
Property, Plant and Equipment [Line Items]
Annual rate of depreciation, minimum	25.00%
Annual rate of depreciation, maximum	33.00%
Manufacturing equipment [Member]
Property, Plant and Equipment [Line Items]
Annual rate of depreciation, minimum	15.00%
Annual rate of depreciation, maximum	33.00%
Office furniture and equipment [Member]
Property, Plant and Equipment [Line Items]
Annual rate of depreciation, minimum	7.00%
Annual rate of depreciation, maximum	33.00%

SIGNIFICANT_ACCOUNTING_POLICIE5

SIGNIFICANT ACCOUNTING POLICIES (Assumptions Used in Estimation of Fair Value of Stock-based Compensation Awards) (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Dividend rate	0.00%	0.00%	0.00%
Expected volatility, minimum	70.00%		80.00%
Expected volatility		74.00%
Expected volatility, maximum	74.00%		100.00%
Risk free interest rate, minimum	0.60%	0.30%	0.30%
Risk free interest rate, maximum	0.80%	0.60%	0.40%
Expected term (in years)	2 years 9 months 22 days	2 years 9 months 22 days
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)			1 year 6 months
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)			5 years 6 months

SIGNIFICANT_ACCOUNTING_POLICIE6

SIGNIFICANT ACCOUNTING POLICIES (Changes in the Liability for Product Warranty) (Details)	12 Months Ended
	Dec. 31, 2014
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Product warranty period	12 months

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Dec. 31, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
INVENTORIES [Abstract]
Raw materials	$919		$1,304
Finished products	1,780	[1]	3,048	[1]
Inventories	2,699		4,352
Inventory delivered to customers but not recognized in revenue	$1,208		$2,109
[1]	Includes amounts of $ 1,208 and $ 2,109 for 2014 and 2013, respectively, with respect to inventory delivered to customers but for which revenue criteria have not been met yet.

OTHER_ACCOUNTS_RECEIVABLE_AND_2

OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES [Abstract]
Indirect taxes	$27	$82
Government of Israel - OCS receivable	357	389
Prepaid expenses and work in progress	738	2,328
Advances to suppliers	26	151
Others	263	142
Other current assets, total	$1,411	$3,092

PROPERTY_AND_EQUIPMENT_NET_Det

PROPERTY AND EQUIPMENT, NET (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]
Property and equipment, cost	$1,272	$1,238
Accumulated depreciation	1,072	985
Property and equipment, net	200	253
Depreciation expenses	87	108	119
Reduction in accumulated depreciation due to fully deprecated equipment no longer in service	0	6,044
Demonstration and rental equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, cost	16	4
Accumulated depreciation
Research and development equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, cost	206	206
Accumulated depreciation	179	146
Manufacturing equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, cost	149	149
Accumulated depreciation	101	77
Office furniture and equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, cost	482	461
Accumulated depreciation	393	378
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, cost	419	418
Accumulated depreciation	$399	$384

OTHER_ACCOUNTS_PAYABLE_AND_ACC2

OTHER ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
OTHER ACCOUNTS PAYABLE AND ACCRUED EXPENSES [Abstract]
Royalties - OCS payable	$827	$690
Commissions	76	62
Provision for product warranty	75	142
Accrued expenses	761	901
Other payables and accrued expenses, total	$1,739	$1,795

COMMITMENTS_AND_CONTINGENCIES_1

COMMITMENTS AND CONTINGENCIES (Royalty Commitments) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Long-term Purchase Commitment [Line Items]
Proceeds from grants received	$55	$150	$109
OCS [Member]
Long-term Purchase Commitment [Line Items]
Royalty rates	3.50%
Percent of grants received paid in royalties	100.00%
Proceeds from grants received	36,685
Accumulated interest, grants	12,709
Accumulated royalties paid	10,918
Total commitment with respect to royalty-bearing participation received, net of royalties paid	38,476
Royalty expenses	827	706	562
BIRD-F [Member]
Long-term Purchase Commitment [Line Items]
Royalty rates	5.00%
Percent of grants received paid in royalties	150.00%
Proceeds from grants received	340
Royalties due based on stated percentage	789
Linkage to the United States Consumer Price Index	434
Accumulated royalties paid	355
Israeli Ministry of Trade [Member]
Long-term Purchase Commitment [Line Items]
Royalty rates	3.00%
Proceeds from grants received	$314
Maximum term for required royalty payments	5 years

COMMITMENTS_AND_CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Operating Leases) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Future minimum rental payments, operating leases:
2015	$601
2016	519
2017	523
Total	1,643
Rental, lease, and maintenance expenses	$883	$941	$1,056

COMMITMENTS_AND_CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Bank Guarantee) (Details) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Guarantor Obligations [Line Items]
Maximum joint ownership of certain principal shareholders of the Company below which bank accelerate repayment	30.00%
Maximum equity with respect to the balance sheet''''s total below which bank accelerate repayment	32.00%
Guarantee expiring April 30, 2015 [Member]
Guarantor Obligations [Line Items]
Bank performance guarantee	32

TAXES_ON_INCOME_Narrative_Deta

TAXES ON INCOME (Narrative) (Details) (USD $)	12 Months Ended			17 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014
Taxes On Income [Line Items]
Tax loss carry forward	$36,619			$36,619
Capital Loss	633
Net change in total valuation allowance	2,326
Israeli corporate tax rate	26.50%	25.00%	25.00%	26.50%
U.S.subsidiary [Member]
Taxes On Income [Line Items]
Tax loss carry forward	8,516			8,516
Brazilian subsidiary [Member]
Taxes On Income [Line Items]
Tax loss carry forward	$742			$742

TAXES_ON_INCOME_Significant_Co

TAXES ON INCOME (Significant Components of Deferred Tax Assets and Liabilities) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
TAXES ON INCOME [Abstract]
Carryforward tax losses	$14,781	$16,638
Research and development credit	513	635
Accrued social benefits and other	767	1,114
Deferred tax assets, gross	16,061	18,387
Less - valuation allowance	-16,061	-18,387
Net deferred tax assets

TAXES_ON_INCOME_Components_of_

TAXES ON INCOME (Components of Income (Loss) Before Income Taxes) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
TAXES ON INCOME [Abstract]
Domestic	$3,350	($1,618)	($5,684)
Foreign	-2,444	198	-183
Loss before taxes on income	$906	($1,420)	($5,867)

TAXES_ON_INCOME_Reconciliation

TAXES ON INCOME (Reconciliation of Theoretical Tax Benefit and Actual Tax Expense) (Details) (USD $)	12 Months Ended			17 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014
TAXES ON INCOME [Abstract]
Income (loss) before income taxes, as reported in the statements of operations	$906	($1,420)	($5,867)
Statutory tax rate in Israel	26.50%	25.00%	25.00%	26.50%
Theoretical tax benefit	240	-355	-1,467
Tax rate differential on foreign subsidiaries	-176	19	-11
Non-deductible expenses and other permanent differences	222	165	185
Change of deferred tax as result of tax rate change		-727
Utilization of tax losses in respect of which deferred tax assets were not recorded in prior years		-469
Differences in taxes arising from foreign currency exchange, net	1,715	186
Losses and timing differences for which no deferred taxes were recorded	-2,326	1,619	1,083
Withholding taxes that were deducted by the Company''s clients	180		120
Other	325	-438	210
Income taxes	$180		$120

SHAREHOLDERS_EQUITY_Narrative_

SHAREHOLDERS' EQUITY (Narrative) (Details) (USD $)	0 Months Ended	1 Months Ended	12 Months Ended	1 Months Ended
In Thousands, except Share data, unless otherwise specified	Feb. 02, 2015	Apr. 24, 2013	Dec. 31, 2014	Feb. 28, 2015	Dec. 31, 2013
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares held by subsidiary			5,189		5,189
Treasury stock, shares			30,843		30,843
Shares issued		1,239,639
Aggregate purchase price		$3,459
Purchase price per share		$2.79
Stock issuance costs		35
Ratio of common shares sold to warrants issued		3
Maximum number of shares callable by warrants		413,213
Exercise price of warrants		$3.49
Exercise of options, shares			79,307
Period before expiration		3 years	7 years
In-the-money options outstanding			721,475
Out of the money options outstanding			44,650
In-the-money options exercisable			544,225
Out of the money options exercisable			44,300
Number of shares available for future grants			24,000
Exercise price, minimum range			$5.25
Exercise price, maximum range			$8.60
Vesting period for plan	1 year		1 year
Unrecognized balance of compensation expenses			$220
Period over which total unrecognized cost related to non-vested share based compensation expected to be recognized			2 years
Subsequent event [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Additional options for future grants authorized				250,000
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period for plan			0 years
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period for plan			4 years

SHAREHOLDERS_EQUITY_Stock_Opti

SHAREHOLDERS' EQUITY (Stock Options Under the Plans) (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Number of options
Exercised	-79,307
Options [Member]
Number of options
Options outstanding, beginning balance	1,013,492
Granted	282,000
Exercised	-493,993
Expired & forfeited	-35,374
Options outstanding, ending balance	766,125	1,013,492
Exercisable at December 31, 2014	588,525
Weighted average exercise price
Options outstanding, beginning balance	$4.34
Granted	$5.85
Exercised	$3.44
Expired & forfeited	$6.41
Options outstanding, ending balance	$5.38	$4.34
Exercisable at December 31, 2014	$5.33
Weighted average remaining contractual term (in years)
Outstanding	3 years 6 months 18 days	3 years 7 months 20 days
Exercisable at December 31, 2014	3 years 2 months 16 days
Aggregate intrinsic value
Outstanding	$5,221	$1,813
Options exercisable	4,050
Vested and expected to vest at December 31, 2014
Number of options	766,125
Weighted average exercise price	$5.38
Weighted average remaining contractual life	3 years 6 months 18 days
Aggregate intrinsic value	$5,221

SHAREHOLDERS_EQUITY_Stock_Opti1

SHAREHOLDERS' EQUITY (Stock Options Under the Plans by Exercise Price) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Minimum exercise price	$5.25
Maximum exercise price	$8.60
Options outstanding at December 31, 2014
Number outstanding	766,125
Options exercisable at December 31, 2014
Number outstanding	588,525
0.7 - 1.95 [Member] | Options [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Minimum exercise price	$0.70
Maximum exercise price	$1.95
Options outstanding at December 31, 2014
Number outstanding	58,150
Weighted average exercise price	$1.83
Weighted average remaining contractual life (in years)	1 year 11 months 23 days
Options exercisable at December 31, 2014
Number outstanding	58,150
Weighted average exercise price	$1.83
Weighted average remaining contractual life	1 year 11 months 23 days
2.56 - 4.86 [Member] | Options [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Minimum exercise price	$2.56
Maximum exercise price	$4.86
Options outstanding at December 31, 2014
Number outstanding	345,700
Weighted average exercise price	$3.50
Weighted average remaining contractual life (in years)	3 years 9 months 25 days
Options exercisable at December 31, 2014
Number outstanding	305,700
Weighted average exercise price	$3.55
Weighted average remaining contractual life	3 years 8 months 8 days
5.0 - 8.60 [Member] | Options [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Minimum exercise price	$5
Maximum exercise price	$8.60
Options outstanding at December 31, 2014
Number outstanding	257,125
Weighted average exercise price	$6.07
Weighted average remaining contractual life (in years)	4 years 1 month 13 days
Options exercisable at December 31, 2014
Number outstanding	119,875
Weighted average exercise price	$5.90
Weighted average remaining contractual life	3 years 6 months 25 days
10.80 - 13.16 [Member] | Options [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Minimum exercise price	$10.80
Maximum exercise price	$13.16
Options outstanding at December 31, 2014
Number outstanding	105,150
Weighted average exercise price	$11.81
Weighted average remaining contractual life (in years)	2 years 1 month 6 days
Options exercisable at December 31, 2014
Number outstanding	104,800
Weighted average exercise price	$11.80
Weighted average remaining contractual life	2 years 1 month 6 days

SHAREHOLDERS_EQUITY_Weighted_A

SHAREHOLDERS' EQUITY (Weighted Average Fair Values of Options Granted) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
SHAREHOLDERS' EQUITY [Abstract]
Weighted average fair values on grant date	$2.70	$1.70	$2.50

SHAREHOLDERS_EQUITY_Department

SHAREHOLDERS' EQUITY (Departmental Allocation of Share-Based Compensation Charge)(Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation charge	$579	$499	$672
Costs of revenue [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation charge	12	7	14
Research and development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation charge	178	117	205
Selling and marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation charge	146	82	167
General and administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation charge	$243	$293	$286

SHAREHOLDERS_EQUITY_Outstandin

SHAREHOLDERS' EQUITY (Outstanding Warrants and Rights) (Details) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2014
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance date	24-Apr-13
Outstanding	333,906
Exercisable	333,906
Exercise price	$3.49
Exercisable through	23-Apr-16

SELECTED_STATEMENTS_OF_OPERATI2

SELECTED STATEMENTS OF OPERATIONS DATA (Narrative) ( Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	item	item
SELECTED STATEMENTS OF OPERATIONS DATA [Abstract]
Number of reportable segments	1
Segment information and revenues from principal customers:
Percent of total revenues benchmark			10.00%
Number of customers exceeding threshold	3	2
Brazil [Member]
Segment information and revenues from principal customers:
Single customer purchases percent of total revenues	22.20%	10.70%
Philippines [Member]
Segment information and revenues from principal customers:
Single customer purchases percent of total revenues	14.90%	15.50%
Israel [Member]
Segment information and revenues from principal customers:
Single customer purchases percent of total revenues	11.70%

SELECTED_STATEMENTS_OF_OPERATI3

SELECTED STATEMENTS OF OPERATIONS DATA (Schedule of Revenues From Sales to Unaffiliated Customers) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Revenues	$23,636	$20,482	$15,786
North America [Member]
Segment Reporting Information [Line Items]
Revenues	1,922	1,687	3,850
Europe [Member]
Segment Reporting Information [Line Items]
Revenues	3,189	4,044	2,970
Asia (Excluding Philippines) [Member]
Segment Reporting Information [Line Items]
Revenues	847	435	1,534
Philippines [Member]
Segment Reporting Information [Line Items]
Revenues	3,544	3,173	1,292
South America (Excluding Brazil) [Member]
Segment Reporting Information [Line Items]
Revenues	4,235	4,579	2,848
Brazil [Member]
Segment Reporting Information [Line Items]
Revenues	6,448	5,469	1,896
Other (Including Israel) [Member]
Segment Reporting Information [Line Items]
Revenues	$3,451	$1,095	$1,396

SELECTED_STATEMENTS_OF_OPERATI4

SELECTED STATEMENTS OF OPERATIONS DATA (Schedule of Property and Equipment, Net, by Geographic Areas) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	$200	$253	$268
Israel [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	151	213	222
Other [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	$49	$40	$46

SELECTED_STATEMENTS_OF_OPERATI5

SELECTED STATEMENTS OF OPERATIONS DATA (Financial Expenses, Net) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Financial Income:
Interest income	$170	$49	$15
Foreign currency exchange gain	193	36	77
Financial Income	363	85	92
Financial expenses:
Interest and bank charges	-40	-117	-108
Foreign currency exchange gain	-655	-259	-298
Other expense	-695	-376	-406
Financial expenses, net	($332)	($291)	($314)

SELECTED_STATEMENTS_OF_OPERATI6

SELECTED STATEMENTS OF OPERATIONS DATA (Schedule of Computation of Basic and Diluted Net Income (Loss) Per Share) (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Numerator:
Numerator for basic net income (loss) per share	$726	($1,420)	($5,987)
Effect of dilutive securities: Option and warrants issued to grantees and investors, respectively
Numerator for dilutive net income (loss) per share	$726	($1,420)	($5,987)
Denominator:
Denominator for dilutive net income (loss) per share - weighted average number of ordinary share	8,088,974	7,340,056	6,442,068
Effect of dilutive securities: Option and warrants issued to grantees and investors, respectively	503,413
Denominator for diluted net income (loss) per share - adjusted weighted average number of ordinary shares	8,592,387	7,340,056	6,442,068

RELATED_PARTY_BALANCES_AND_TRA2

RELATED PARTY BALANCES AND TRANSACTIONS (Narrative) (Details)

1 Months Ended

12 Months Ended

0 Months Ended

1 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Apr. 24, 2013

Nov. 30, 2012

Nov. 30, 2012

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Apr. 23, 2013

Dec. 31, 2014

Jun. 30, 2013

Jun. 30, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

USD ($)

USD ($)

ILS

USD ($)

USD ($)

USD ($)

Transactions With Related Parties [Member]

Transactions With Related Parties [Member]

Transactions With Related Parties [Member]

Principal shareholder [Member]

Principal shareholder [Member]

Chairman of the Company's Board of Directors [Member]

President and Chief Executive Officer [Member]

Consultant [Member]

Consultant [Member]

Consultant [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Related Party Transaction [Line Items]

Joint Ownership Percentage of Principal Shareholders Which Are Principal Shareholder of Affiliates

38.00%

Aggregate net amounts of lease payments

$417

$410

$438

Related Party Transaction, Expenses from Transactions with Related Party

39

43

37

Loan proceeds from related party

750

2,900

750

Increased in average Israeli Consumer Price Index

1.80%

1.60%

Financial expenses (income)

-332

-291

-314

27

23

Aggregate purchase price

3,459

3,459

1,100

50

Aggregate net lease payments

$39

$43

$37

RELATED_PARTY_BALANCES_AND_TRA3

RELATED PARTY BALANCES AND TRANSACTIONS (Schedule of Balances with Related Parties) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets:
Trade receivables	$5,477	$5,723
Other accounts receivable and prepaid expenses	1,411	3,092
Liabilities:
Trade Payables	1,524	2,257
Other accounts payable and accrued expenses	1,739	1,795
Balances With Related Parties [Member]
Assets:
Trade receivables	2	11
Other accounts receivable and prepaid expenses
Liabilities:
Trade Payables	155	159
Other accounts payable and accrued expenses	$11	$46

RELATED_PARTY_BALANCES_AND_TRA4

RELATED PARTY BALANCES AND TRANSACTIONS (Schedule of Transactions with Related Parties) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Related Party Transaction [Line Items]
Revenues	$23,636	$20,482	$15,786
Expenses:
Cost of sales	8,693	7,890	6,182
Operating expenses:
Research and development	5,812	5,615	6,102
Sales and marketing	7,295	7,592	8,515
General and administrative	2,262	2,051	2,107
Financial expenses (income)	-332	-291	-314
Transactions With Related Parties [Member]
Related Party Transaction [Line Items]
Revenues	19	403	451
Expenses:
Cost of sales	56	54	66
Operating expenses:
Research and development	249	208	198
Sales and marketing	125	126	181
General and administrative	60	53	57
Financial expenses (income)		$27	$23

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details)	0 Months Ended	12 Months Ended
	Feb. 02, 2015	Dec. 31, 2014
SUBSEQUENT EVENTS [Line Items]
Number of shares available for grant approved by Board of Directors		24,000
Vesting period	1 year	1 year
Subsequent Event [Member] | Share Option Plan 2013 [Member]
SUBSEQUENT EVENTS [Line Items]
Number of outstanding shares reserved before increment	500,000
Number of outstanding shares reserved	750,000
Number of shares available for grant approved by Board of Directors	191,750
Number of shares available for grant which are subject to shareholders approval	10,000